A commercializing a retinal implant to restore vision.
LambdaVision, Inc. is commercializing a retinal implant to restore vision for the millions of patients suffering from retinitis pigmentosa (RP) and age-related macular degeneration (AMD).
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 9, 2020 | Grant | $5M | 1 | NASA | — | Detail |
Aug 29, 2016 | Grant | $1.04M | 1 | National Science Foundation | — | Detail |
Dec 8, 2014 | Grant | $179.93K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
NASA | Yes | Grant |
National Science Foundation | Yes | Grant |